Our CEO Thomas Schmidt was invited on stage at the UC Davis Innovation Institute for Food and Health (IIFH) Conference in Sacramento, to discuss Precision Protein Nutrition in the Ozempic Era.
GLP-1 therapies are transforming obesity treatment, but they are not a long-term solution on their own. The majority of patients discontinue within one to two years, and most who stop quickly regain the majority of weight lost.
Quick weight loss isn’t without consequences: GLP-1 patients often lose lean muscle mass along with fat mass. Preventing this requires appropriate nutrition: high-quality proteins.
As the Greeks said: ‘Let food be your medicine’. And in this case, the medicine is not just more protein, but better protein.
Beta-lactoglobulin (BLG) the best protein in milk, stands out:
- Supports muscle maintenance during weight loss
- Contributes to metabolic health and satiety
- Provides a complete amino acid composition unmatched by plant proteins
The problem? Dairy-derived BLG is in very limited supply, with producers sold out well into 2026.
Precision fermentation enables resilient, scalable, and cost-competitive BLG production anywhere in the world — ensuring ample access to the best protein for long-term health.
The message was clear: nutrition must work hand in hand with medicine if we are to shape the future of health. We are proud to help make this a reality with precision fermentation.
